Search Results

Asensus Surgical, Inc. announced that it has entered into a non-binding letter of intent with KARL STORZ SE & Co. KG, an independent, family-owned global medical technology company to engage in diligence and negotiations regarding the terms of a potential transaction whereby KARL STORZ may acquire Asensus.

Asensus Surgical, Inc. today announced that it has entered into a definitive merger agreement (the “Merger Agreement”) with KARL STORZ Endoscopy-America, Inc.

Pioneering MedTech company KARL STORZ is proud to announce the release of the CollaboratOR 3D app for Apple Vision Pro.

The family-owned MedTech company KARL STORZ announces the acquisition of innovative software manufacturer Innersight Labs Ltd., headquartered in London.

KARL STORZ announced it will centralize management of its United States organizations, including its research and development, manufacturing, and commercial operations, to bring more innovative products to market worldwide with greater speed.

Luciole Medical AG, a Swiss medical technology company specialized in brain monitoring, announced the acquisition of Spiegelberg GmbH & Co. KG, an established medical device company and provider of highly specialized devices and consumables for neurosurgery, from SHS Capital.

Secarna Pharmaceuticals GmbH & Co. KG and Orbit Discovery Ltd. today announced that they have entered into a collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide (ASO) therapeutics.

Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced an agreement with MEDICE Arzneimittel Pütter GmbH&Co.KG (Medice – The Health Family), for Medice to market Vafseo® (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor developed by Akebia to treat anemia due to chronic kidney disease (CKD), in Europe.